Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - alteplase -

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 5000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - heparin sodium, quantity: 1000 iu/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 26 november 2001: prophylaxis and treatment of thromboembolic disorders such as thrombophlebitis, pulmonary embolism, coronary or venous thrombosis and occlusive vascular disease. as a low-dose regimen for the prevention of thromboembolic complications arising as a result of cardiac and arterial surgery. as an anticoagulant during blood transfusions, extracorporeal circulation, dialysis and other perfusion techniques and in blood samples for laboratory purposes.

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - white shrimp -

Australia - English - Department of Health (Therapeutic Goods Administration)

stallergenes australia pty ltd - secale cereale -

Australia - English - Department of Health (Therapeutic Goods Administration)

diagnostica stago pty ltd - ct875 - fibrinolysis ivds - ivds that are intended to be used in testing to provide information about fibrinolysis, fibrin degradation products and components involved in the process of clot breakdown. alpha-2-antiplasmin, aprotinin, d-dimer, fibrinogen degradation product (fdp), plasmin, plasmin-alpha-2-antiplasmin complex (pap), plasminogen activator inhibitor, plasminogen, soluble fibrin monomer complex, thrombin activating fibrinolysis inhibitor, tissue plasminogen activator, total degradation product (tdp), urokinase plasminogen activator.

Ireland - English - HPRA (Health Products Regulatory Authority)

meda health sales ireland limited - tranexamic acid - film coated tablet - 500 milligram - tranexamic acid

Singapore - English - HSA (Health Sciences Authority)

link healthcare singapore pte ltd - aprotinin - injection - 500000 kiu/50 ml - aprotinin 500000 kiu/50 ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

norgine pharmaceuticals ltd - acenocoumarol - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

hameln pharma ltd - midazolam hydrochloride - solution for injection - 2mg/1ml